A Randomized, Double-Blind, Placebo-Controlled, 2-Period, Crossover Study to Evaluate the Effects of Ezetimibe on the Plasma Appearance of 7-Ketocholesterol After an Oral Bolus in Patients With Primary Hypercholesterolemia
The purpose of this study is to test the effects of Zetia™ (ezetimibe) 10 milligrams (mg) on the absorption of oxysterol into the blood following a meal containing oxysterol.
100 Clinical Results associated with Merck/Schering-Plough Pharmaceuticals
0 Patents (Medical) associated with Merck/Schering-Plough Pharmaceuticals
100 Deals associated with Merck/Schering-Plough Pharmaceuticals
100 Translational Medicine associated with Merck/Schering-Plough Pharmaceuticals